International Journal of Drug Policy
Volume 21, Issue 6 , Pages 501-506 , November 2010

High and low threshold service provision in drug-free settings: Practitioner views

Received 23 November 2009 ,Revised 5 March 2010 ,Accepted 16 March 2010.

References 

  1. Allen JP, Litten RZ. Treatment of drug and alcohol abuse: An overview of major strategies and effectiveness. In:  McCrady BS,  Epstein EE editor. Addictions: A comprehensive guidebook. Oxford: Oxford University Press; 1999;p. 385–395
  2. Appel PW, Ellison AA, Jansky HK, Oldak R. Barriers to enrollment in drug abuse treatment and suggestions for reducing them: Opinions of drug injecting street outreach clients and other system stakeholders. The American Journal of Drug and Alcohol Abuse. 2004;30(1):129–153
  3. Ball AL. HIV, injecting drug use and harm reduction: A public health response. Addiction. 2007;102(5):684–690
  4. Bastos FI, Strathdee SA. Evaluating effectiveness of syringe exchange programmes: Current issues and future prospects. Social Science & Medicine. 2000;51:1771–1782
  5. Brochu S. Abstinence versus nonabstinence: The objectives of alcoholism rehabilitation programs in Quebec. Journal of Psychoactive Drugs. 1990;22(1):15–21
  6. Cox W, Rosenberg H, Hodgins C, Maccartney J, Maurer K. United Kingdom and United States healthcare providers’ recommendations of abstinence versus controlled drinking. Alcohol and Alcoholism. 2004;39(2):130–134
  7. Dawe S, Richmond R. Controlled drinking as a treatment goal in Australian alcohol treatment agencies. Journal of Substance Abuse Treatment. 1997;14(1):81–86
  8. Donovan M, Heather N. Acceptability of the controlled-drinking goal among alcohol treatment agencies in New South Wales, Australia. Journal of Studies on Alcohol. 1997;58(3):253–256
  9. Eversman, M. H. (2009). Harm reduction in outpatient drug-free substance abuse treatment settings (doctoral dissertation, State University of New York at Albany, 2009). ProQuest Dissertations.
  10. Gallon S, Gabriel R, Knudsen J. The toughest job you’ll ever love: A Pacific Northwest treatment workforce survey. Journal of Substance Abuse Treatment. 2003;24(3):183–196
  11. Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS. 2001;15(11):1329–1341
  12. Hilton BA, Thompson R, Moore-Dempsey L, Janzen RG. Harm reduction theories and strategies for control of human immunodeficiency virus: A review of the literature. Journal of Advanced Nursing. 2001;33(3):357–370
  13. Keen J, Oliver P. Commissioning pharmacological treatments for drug users: A brief review of the evidence base. Drugs: Education, Prevention, and Policy. 2004;11(2):149–156
  14. Klaw E, Luft S, Humphreys K. Characteristics and motives of problems drinkers seeking help from moderation management self-help groups. Cognitive and Behavioral Practice. 2003;10(4):384–389
  15. Klingemann H, Rosenberg H. Acceptance and therapeutic practice of controlled drinking as an outcome goal by swiss alcohol treatment programmes. European Addiction Research. 2009;15(3):121–127
  16. Koutroulis G. That original tension: Negotiating abstinence in clinicians’ accounts of harm reduction in nonresidential treatment of heroin withdrawal. Journal of Substance Abuse Treatment. 2000;19(1):89–98
  17. Lenton S, Single E. The definition of harm reduction. Drug and Alcohol Review. 1998;17(2):213–219
  18. Libretto S, Weil J, Nemes S, Linder N, Johansson A. Snapshot of the substance abuse treatment workforce in 2002: A synthesis of current literature. Journal of Psychoactive Drugs. 2004;36(4):489–497
  19. MacDonald M, Law M, Kaldor J, Hales J, Dore GJ. Effectiveness of needle and syringe programmes for preventing HIV transmission. International Journal of Drug Policy. 2003;14(5–6):353–357
  20. Marlatt G, Tapert S. Harm reduction: Reducing the risks of addictive behaviors. In:  Baer J,  Marlatt G,  McMahon R editor. Addictive behaviors across the lifespan: Prevention, treatment, and policy issues. Newbury Park: Sage Publications; 1993;p. 243–273
  21. Marlatt, G., Tucker, J., Donovan, D., & Vuchinich, R. (1997). Help-seeking by substance abusers: The role of harm reduction and behavioral-economic approaches to facilitate treatment entry and retention. In L. Onken, J. Blaine, & J. Boren (Eds.), Beyond the therapeutic alliance: Keeping the drug-dependent individual in treatment (pp. 44–84). National Institute on Drug Abuse Research Monograph 165. Rockville, MD: National Institutes of Health.
  22. Marsch LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior, and criminality: A meta-analysis. Addiction. 1998;93(4):515–532
  23. McKeganey N, Morris Z, Neale J, Robertson M. What are drug users looking for when they contact drug services: Abstinence or harm reduction?. Drugs: Education, Prevention, and Policy. 2004;11(5):423–435
  24. Moustakas C. Phenomenological research methods. Thousand Oaks, CA: Sage; 1994;
  25. Ogborne A, Birchmore-Timney C. Support for harm-reduction among staff of specialized addiction treatment services in Ontario, Canada. Drug and Alcohol Review. 1998;17(1):51–58
  26. Perkins D, Cox W, Levy L. Therapists’ recommendations of abstinence or controlled drinking as treatment goals. Journal of Studies on Alcohol. 1981;42(3):304–311
  27. Quinn JF, Bodenhamer-Davis E, Koch DS. Ideology and the stagnation of AODA treatment modalities in America. Deviant Behavior. 2004;25(2):109–131
  28. Robertson I, Heather N. A survey of controlled drinking treatment in Britain. British Journal on Alcohol and Alcoholism. 1982;17(3):102–105
  29. Rosenberg H, Davis L. Acceptance of moderate drinking by alcohol treatment services in the United States. Journal of Studies on Alcohol. 1994;55(2):167–172
  30. Rosenberg H, Devine E, Rothrock N. Acceptance of moderate drinking by alcoholism treatment services in Canada. Journal of Studies on Alcohol. 1996;57(5):559–562
  31. Rosenberg H, Melville J. Controlled drinking and controlled drug use as outcome goals in British treatment services. Addiction Research and Theory. 2005;13(1):85–92
  32. Rosenberg H, Melville J, Levell D, Hodge J. A 10-year follow-up survey of acceptability of controlled drinking in Britain. Journal of Studies on Alcohol. 1992;53(5):441–446
  33. Rosenberg H, Melville J, McLean P. Nonpharmacological harm-reduction interventions in British substance-misuse services. Addictive Behaviors. 2004;29(6):1225–1229
  34. Rosenberg H, Phillips K. Acceptability and availability of harm-reduction interventions for drug abuse in American substance abuse treatment agencies. Psychology of Addictive Behaviors. 2003;17(3):203–210
  35. Rush B, Ogborne A. Acceptability of nonabstinence treatment goals among alcoholism treatment programs. Journal of Studies on Alcohol. 1986;47(2):146–150
  36. Sanchez-Craig M, Lei H. Disadvantages to imposing the goal of abstinence on problem drinkers: An empirical study. British Journal of Addiction. 1986;81(4):505–512
  37. Schippers GM, Nelissen H. Working with controlled use as a goal in regular substance use outpatient treatment in Amsterdam. Addiction Research & Theory. 2006;14(1):51–58
  38. Smith, B. (2005). Inter-agency collaboration: Policy and practice in child welfare and substance abuse. Paper presented at International social work practice research symposium.
  39. Sobell M, Sobell L, Bogardis J, Leo G, Skinner W. Problem drinkers’ perceptions of whether treatment goals should be self-selected or therapist selected. Behavior Therapy. 1992;23:43–52
  40. Sorensen JL, Copeland AL. Drug abuse treatment as an HIV prevention strategy: A review. Drug and Alcohol Dependence. 2000;59(1):17–31
  41. Tammi T. The harm reduction school of thought: Three fractions. Contemporary Drug Problems. 2004;31(3):381–399
  42. United States Center for Disease Control. (2002). Methadone maintenance treatment. Available online http://www.cdc.gov/idu/facts/MethadoneFin.pdf (retrieved November 2005).
  43. White WL, Boyle M, Loveland D. Alcoholism/addiction as a chronic disease: From rhetoric to clinical reality. Alcoholism Treatment Quarterly. 2002;20(3–4):107–130

PII: S0955-3959(10)00059-9

doi: 10.1016/j.drugpo.2010.03.005

International Journal of Drug Policy
Volume 21, Issue 6 , Pages 501-506 , November 2010

Article Tools